L. Fredrik Jarskog, MD

North Carolina Psychiatric Research Center, Department of Psychiatry, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina

  • 3Articles
  • 3.7KReads
  • 2006–2025Active
  • 6Collaborators

About

L. Fredrik Jarskog, MD is affiliated with North Carolina Psychiatric Research Center, Department of Psychiatry, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. L. Fredrik Jarskog has authored or co-authored 3 peer-reviewed articles published across the Journal of Clinical Psychiatry and the Primary Care Companion for CNS Disorders between 2006 and 2025. Their work focuses on Schizophrenia/Schizoaffective Disorders.

Publications

JCP
Brexpiprazole for the Treatment of Co-Occurring Schizophrenia and Substance Use Disorder
Original Research

Brexpiprazole for the Treatment of Co-Occurring Schizophrenia and Substance Use Disorder

October 13, 2025

This pilot trial suggests that brexpiprazole might be beneficial in reducing substance craving and use and improve quality of life in this difficult-to-treat patient population.
, , , et al
JCP
Educational Activity

Neuroprotection in Schizophrenia

September 15, 2006

,
JCP
Academic Highlights

Preventing Clinical Deterioration in the Course of Schizophrenia: The Potential for Neuroprotection.

June 15, 2006

, ,

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe